<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03605914</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-18-0242</org_study_id>
    <nct_id>NCT03605914</nct_id>
  </id_info>
  <brief_title>Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty</brief_title>
  <official_title>Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the level of pain control in patients receiving&#xD;
      non-steroidal anti-inflammatory drugs (NSAIDs) to those receiving opioids in the&#xD;
      postoperative period after endoscopic sinus surgery (ESS) and/or septoplasty.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Actual">July 5, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</measure>
    <time_frame>24 hours (day 1 after operation)</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</measure>
    <time_frame>48 hours (day 2 after operation)</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</measure>
    <time_frame>72 hours (day 3 after operation)</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</measure>
    <time_frame>120 hours (day 5 after operation)</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Bleeding Complications</measure>
    <time_frame>5 days after operation</time_frame>
    <description>Bleeding complications are defined as complications necessitating a trip to the emergency room or requiring intervention for epistaxis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Constipation</measure>
    <time_frame>5 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Nausea or Vomiting</measure>
    <time_frame>5 days after operation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty</condition>
  <arm_group>
    <arm_group_label>NSAID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diclofenac</intervention_name>
    <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
    <arm_group_label>NSAID</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norco</intervention_name>
    <description>The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
    <arm_group_label>opioid</arm_group_label>
    <other_name>Hydrocodone-Acetaminophen combination medication</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  english speaking&#xD;
&#xD;
          -  candidates for endoscopic sinus surgery as determined by medical necessity by the&#xD;
             treating rhinologist&#xD;
&#xD;
          -  scheduled for surgery at Texas Sinus Institute&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergy to either NSAIDs or opioids&#xD;
&#xD;
          -  contraindication to NSAIDs (ex. gastritis, chronic kidney disease)&#xD;
&#xD;
          -  surgical plan exceeding basic endoscopic sinus surgery&#xD;
&#xD;
          -  use of anticoagulation&#xD;
&#xD;
          -  the presence of any pain disorder&#xD;
&#xD;
          -  the current usage of any analgesic medication&#xD;
&#xD;
          -  history of opioid addiction&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  history of chronic pain or fibromyalgia&#xD;
&#xD;
          -  current daily use of NSAIDs, acetaminophen, opioids or other analgesics (pregabalin,&#xD;
             tramadol, etc)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Citardi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 4, 2018</study_first_submitted>
  <study_first_submitted_qc>July 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2018</study_first_posted>
  <results_first_submitted>June 27, 2021</results_first_submitted>
  <results_first_submitted_qc>July 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 20, 2021</results_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Martin J Citardi, MD</investigator_full_name>
    <investigator_title>Professor and Chairman, Department of Otorhinolaryngology - Head and Neck Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 26, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/14/NCT03605914/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NSAID</title>
          <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
        </group>
        <group group_id="P2">
          <title>Opioid</title>
          <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Day 1 Assessment</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Day 2 Assessment</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Day 3 Assessment</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Day 5 Assessment</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NSAID</title>
          <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
        </group>
        <group group_id="B2">
          <title>Opioid</title>
          <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="57"/>
            <count group_id="B2" value="43"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.4" spread="15.7"/>
                    <measurement group_id="B2" value="46.2" spread="15.3"/>
                    <measurement group_id="B3" value="45.7" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants with history of anxiety</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants with history of depression</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants with history of migraine</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants with history of temporomandibular joint (TMJ) dysfunction</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants with history of fibromyalgia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants with history of pain disorder</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants currently on pain medication</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants currently on opioid</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants currently on NSAID</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                    <count group_id="B2" value="43"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
        <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
        <time_frame>24 hours (day 1 after operation)</time_frame>
        <population>Data was not collected for 26 in the NSAID arm and 17 in the opioid arm.</population>
        <group_list>
          <group group_id="O1">
            <title>NSAID</title>
            <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
          </group>
          <group group_id="O2">
            <title>Opioid</title>
            <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
          <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
          <population>Data was not collected for 26 in the NSAID arm and 17 in the opioid arm.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.2" spread="25.3"/>
                    <measurement group_id="O2" value="40.7" spread="29.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
        <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
        <time_frame>48 hours (day 2 after operation)</time_frame>
        <population>Data was not collected for 25 in the NSAID arm and 16 in the opioid arm.</population>
        <group_list>
          <group group_id="O1">
            <title>NSAID</title>
            <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
          </group>
          <group group_id="O2">
            <title>Opioid</title>
            <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
          <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
          <population>Data was not collected for 25 in the NSAID arm and 16 in the opioid arm.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.2" spread="25.1"/>
                    <measurement group_id="O2" value="28.3" spread="23.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
        <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
        <time_frame>72 hours (day 3 after operation)</time_frame>
        <population>Data was not collected for 26 in the NSAID arm and 15 in the opioid arm.</population>
        <group_list>
          <group group_id="O1">
            <title>NSAID</title>
            <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
          </group>
          <group group_id="O2">
            <title>Opioid</title>
            <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
          <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
          <population>Data was not collected for 26 in the NSAID arm and 15 in the opioid arm.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.9" spread="20.4"/>
                    <measurement group_id="O2" value="27.9" spread="21.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
        <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
        <time_frame>120 hours (day 5 after operation)</time_frame>
        <population>Data was not collected for 27 in the NSAID arm and 19 in the opioid arm.</population>
        <group_list>
          <group group_id="O1">
            <title>NSAID</title>
            <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
          </group>
          <group group_id="O2">
            <title>Opioid</title>
            <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)</title>
          <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
          <population>Data was not collected for 27 in the NSAID arm and 19 in the opioid arm.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.2" spread="20.3"/>
                    <measurement group_id="O2" value="18.9" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Bleeding Complications</title>
        <description>Bleeding complications are defined as complications necessitating a trip to the emergency room or requiring intervention for epistaxis.</description>
        <time_frame>5 days after operation</time_frame>
        <population>Data was not collected for 27 in the NSAID arm and 19 in the opioid arm.</population>
        <group_list>
          <group group_id="O1">
            <title>NSAID</title>
            <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
          </group>
          <group group_id="O2">
            <title>Opioid</title>
            <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Bleeding Complications</title>
          <description>Bleeding complications are defined as complications necessitating a trip to the emergency room or requiring intervention for epistaxis.</description>
          <population>Data was not collected for 27 in the NSAID arm and 19 in the opioid arm.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Constipation</title>
        <time_frame>5 days after operation</time_frame>
        <population>No data were collected for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>NSAID</title>
            <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
          </group>
          <group group_id="O2">
            <title>Opioid</title>
            <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Constipation</title>
          <population>No data were collected for this outcome measure.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Nausea or Vomiting</title>
        <time_frame>5 days after operation</time_frame>
        <population>No data were collected for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>NSAID</title>
            <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
          </group>
          <group group_id="O2">
            <title>Opioid</title>
            <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Nausea or Vomiting</title>
          <population>No data were collected for this outcome measure.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>5 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>NSAID</title>
          <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.&#xD;
diclofenac: The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
        </group>
        <group group_id="E2">
          <title>Opioid</title>
          <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).&#xD;
Norco: The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Martin J. Citardi, MD, Professor and Chair, Department of Otorhinolaryngology</name_or_title>
      <organization>The University of Texas Health Science Center at Houston</organization>
      <phone>(713) 500-5410</phone>
      <email>Martin.J.Citardi@uth.tmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

